Ventilator-associated pneumonia: A review

Journal of Intensive Care Medicine

Volumn 21, Issue 4, 2006, Pages 211-226

  Davis, Kimberly A ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hospital acquired; Infection; Nosocomial; Pneumonia; Ventilator

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFTRIAXONE; CEPHALOSPORIN; ERTAPENEM; LINEZOLID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL FLORA; BACTERIUM CULTURE; CLINICAL TRIAL; HEALTH CARE FINANCING; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, ASPIRATION; PNEUMONIA, VENTILATOR-ASSOCIATED; SINUSITIS; VENTILATOR WEANING;

EID: 33745759201     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066606288837     Document Type: Review

References (217)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. Chastre J, Fagon YT. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
3. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 - May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
4. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115-2121.
5. Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother. 1997;39:527-535.
6. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312-1317.
7. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887-892.
8. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA. 1993;270:1965-1970.
9. Rello J, Diaz E, Roque M, et al. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med. 1999;159:1742-1746.
10. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Internal Med. 1998;129:433-440.
11. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of severity of illness and the etiologic agent. Crit Care Med. 1997;25:1862-1867.
12. Rello J, Jubert P, Valles J, et al. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 1996;23:973-978.
13. Kollef MH, Silver P, Murphy DM, et al. The effect of late onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108:1655-1662.
14. Fagan YT, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-288.
15. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant with methicillin sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545-1549.
16. Lees AW, NcMaught W. Bacteriology of lower-respiratory-tract secretions, sputum, and upper-respiratory-tract secretions in "normals" and chronic bronchitics. Lancet. 1959;2:1112-1115.
17. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med. 1961;265:1273-1278.
18. Mason CM and Nelson S. Normal host defenses and impairments associated with the delayed resolution of pneumonia. Semin Respir Infect. 1992;7:243-255.
19. Lillehoj ER and Kim KC. Airway mucus: its components and function. Arch Pharm Res. 2002;25:770-780.
20. Salanthe M, Wanner A. Nonspecific host defenses: mucociliary clearance and cough. In: Neiderman M, ed. Respiratory Infections. Philadelphia: Saunders; 1994:17-32.
21. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev. 2000;173:39-51.
22. Zeiher BG, Hornick DB. Pathogenesis of respiratory infections and host defense. Curr Opin Pulm Med. 1996;2:166-173.
23. Gal TJ. How does tracheal intubation alter respiratory mechanics? Probl Anesth 1988;2:191-200.
24. Klainer AS, Tumdorf H, Wu WH, Maewal H, Allender P. Surface alterations due to endotracheal intubation. Am J Med. 1975;58:674-683.
25. Cooper JD, Grillo HC. Experimental production and prevention of injury due to cuffed tracheal tubes. Surg Gynecol Obstet. 1969;129:1235-1241.
26. Levine SA, Niederman MS. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clin Chest Med. 1991;12:523-543.
27. Bone DK, Davis JL, Zuidema GD, Cameron JL. Aspiration pneumonia: prevention of aspiration in patients with tracheostomies. Ann Thorac Surg. 1974;18:30-37.
28. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora in hospitalized patients: emergence of Gram-negative bacilli. N Engl J Med. 1969;281:1137-1140.
29. Sigalet DL, Mackenzie SL, Hameed SM. Enteral nutrition and mucosal immunity: implications for feeding strategies in surgery and trauma. Can J Surg. 2004;47:109-116.
30. Rodriguez JL, Gibbons KJ, Bitzer LG, et al. Pneumonia: incidence, risk factors, and outcome in injured patients. J Trauma. 1991;31:907-914.
31. Croce MA, Fabian TC, Waddle-Smith L, et al. Identification of early predictors for posttraumatic pneumonia. Am Surg. 2001; 67:105-110.
32. Croce MA, Fabian TC, Tolley EA. A formula for the prediction of posttraumatic pneumonia based on early anatomic and physiologic parameters. J Trauma. 2003;54:724-730.
33. McRitchie DI, Matthews JG, Fink MP. Pneumonia in patients with multiple trauma. Clin Chest Med. 1995;16:135-146.
34. Eckert MJ, Davis KA, Reed RL, et al. Urgent airways after trauma: who gets pneumonia? J Trauma. 2004;57:750-755.
35. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury: incidence, risk factors and association with ventilator-associated pneumonia. Am J Respir Crit Care Med. 1999;159:188-198.
36. Craven DE, Connolly MG Jr, Lichtenberg DA, Primeau PJ, McCabe WR. Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. N Engl J Med. 1982;306:1505-1509.
37. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986;133:792-796.
38. Dreyfuss D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no changes. Am Rer Respir Dis. 1991;143:738-743.
39. Kollef MH, Shapiro SD, Fraser VJ, et al. Mechanical ventilation with or without 7-day circuit changes: a randomized controlled trial. Ann Intern Med. 1995;123:168-174.
40. Long MN, Wickstrom G, Grimes A, Benton CF, Belcher B, Stamm AM. Prospective randomized study of ventilator-associated pneumonia in patients with 1 versus 3 ventilator circuit changes per week. Infect Control Hosp Epidemiol. 1996;17:14-19.
41. Cook D, De Jonghe B, Brochard L, Brun-Buisson C. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA. 1998;279:781-787.
42. Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL; American Association for Respiratory Care. Care of the ventilator circuit and its relationship to ventilator associated pneumonia. Respir Care. 2003;48:869-879.
43. Fink JB, Krause SA, Barrett L, Schaaff D, Alex CG. Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia. Chest. 1998; 113:405-411.
44. Kola A, Eckmass R, Gastmeier P. Efficacy of heat and moisture exchanges in preventing ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Intensive Care Med. 2005;31:5-11.
45. Prin S, Chergui K, Augarde R, Page B, Jardin F, Vieillard-Baron A. Ability and safety of a heated humidifier to control hypercapnic acidosis in severe ARDS. Intensive Care Med. 2002;28:1756-1760.
46. Iotti GA, Olivei MC, Braschi A. Mechanical effects of heatmoisture exchangers in ventilated patients. J Crit Care. 1999; 3:R77-R82.
47. Campbell RS, Davis K Jr., Johannigman JA, Branson RD. The effects of passive humidifier dead space on respiratory variables in paralyzed and spontaneously breathing patients. Respir Care. 2000;45:306-312.
48. Kirton OC, DeHaven B, Morgan J, Morejon O, Civetta J. A prospective randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. Chest. 1997;112:1055-1059.
49. Boisson C, Viviand X, Arnaud S, Thomachot L, Miliani Y, Martin C. Changing a hydrophobic heat and moisture exchanger after 48 hours rather than 24 hours: a clinical and microbiological evaluation. Intensive Care Med. 1999; 25:1237-1243.
50. Markowicz P, Ricard JD, Dreyfuss D, et al. Safety, efficacy and cost-effectiveness of mechanical ventilation with humidifying filters changed every 48 hours: a prospective, randomized study. Crit Care Med. 2000;28:665-671.
51. Hess DR, Branson RD. Humidification. In: Branson RD, Hess DR, Chatburn RL, eels. Respiratory Care Equipment, 2nd ed. Philadelphia: Lippencott; 1999:101-132.
52. Cereda M, Villa F, Colombo E, Greco G, Nacoti M, Pesenti A. Closed system endotracheal suctioning maintains lung volume during volume-controlled mechanical ventilation. Intensive Care Med. 2001;27:648-654.
53. Heyland DK, Cook DJ, Dodek PM. Prevention of ventilator-associated pneumonia: current practice in Canadian intensive care units. J Crit Care. 2002;17:161-167.
54. Ritz R, Scott LR, Coyle MD, Pierson DJ. Contamination of a multiple-use suction catheter in a closed-circuit system compared to contamination of a disposable, single-use suction catheter. Respir Care. 1986;31:1086-1091.
55. Deppe SA, Kelly JW, Thoi LL, et al. Incidence of colonization, nosocomial pneumonia, and mortality in critically ill patients using a Trach Care closed-suction system versus an open-suction system: prospective randomized study. Crit Care Med. 1990;18:1389-1393.
56. Johnson KL, Kearney PA, Johnson SB, Niblett JB, MacMillian NL, McClain RE. Closed versus open endotracheal suctioning: costs and physiologic consequences. Crit Care Med. 1994; 22:658-666.
57. Mastro TD, Fields BS, Breiman RF, Campbell J, Plikaytis BD, Spika JS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis. 1991;163:667-671.
58. Reboli AC, Koshinski R, Arias K, Marks-Austin K, Stieritz D, Stull TL. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol. 1996;17:741-743.
59. Kollef MH, Von Harz B, Prentice D, et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest. 1997;112:765-773.
60. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004;53(RR-3):1-36.
61. Bernhardt J, Knoke M. Recent studies on the microbial ecology of the upper gastrointestinal tract. Infection. 1989;17:259-263.
62. Craven DE, Steger KA. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology, and prevention in 1996. Semin Respir Infect. 1996;11:32-53.
63. Vincent JL. Ventilator-associated pneumonia. J Hosp Infect. 2004;57:272-280.
64. Niederman MS, Craven DE. Devising strategies for preventing nosocomial pneumonia - should we ignore the stomach? Clin Infect Dis. 1997;24:320-323.
65. Atherton ST, White DJ. Stomach as a source of bacteria colonizing respiratory tract during artificial ventilation. Lancet. 1978;2:968-969.
66. Hillman KM, Riordan R, O'Farrell SM, Tabaqchali S. Colonization of the gastric contents in critically ill patients. Crit Care Med. 1982;20:444-447.
67. Daschner F, Kappstein I, Engels I, et al. Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents? Infect Control Hosp Epidemiol. 1988;9:59-65.
68. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330:377-381.
69. Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Recomm Rep. 1997;46(RR1):1-79.
70. Inglis TJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM. Gastroduodenal dysfunction and bacterial colonization of the ventilated lung. Lancet. 1993;341:911-913.
71. Pilchman J, Lefton HB, Braden GL. Cytoprotection and stress ulceration. Med Clin North Am. 1991;75:853-863.
72. Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med. 1987;83:125-127.
73. Cook DJ. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia: best evidence synthesis. Scand J Gastroenterol Suppl. 1995;210:48-52.
74. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996;275:308-314.
75. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791-797.
76. Bonten MJ, Gaillard CA, de Leeuw PW, Stobberingh EE. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 1997;24:309-319.
77. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14:801-807.
78. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480.
79. Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371-1375.
80. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 1993;104:1230-1235.
81. Rello J, Ricart M, Ausina V, Net A, Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome and risk factors. Chest. 1992;102:1562-1565.
82. Shah PM. Staphylococcus aureus in lower respiratory infections: clinical relevance of antimicrobial resistance. Semin Respir Infect. 2001;16:196-202.
83. Stevens DL. Community-acquired Staphylococcus aureus infections: increasing virulence and emerging methicillin resistance in the new millennium. Curr Opin Infect Dis. 2003;16:189-193.
84. Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis. 1990;142:1320-1324.
85. Pujol M, Corbella X, Pena C, et al. Clinical and epidemiological findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis. 1998;17:622-628.
86. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
87. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet. 2002;359:753-759.
88. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev. 2001:14:933-951.
89. Rello J, Ausina V, Ricart M, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator- associated pneumonia. Intensive Care Med. 1994;20:193-198.
90. Rello J, Mariscal D, March F, et al. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med. 1998;157:912-916.
91. Hauser AR, Cobb E, Bodi M, et al. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med. 2002;30:521-528.
92. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev. 1996;9:148-165.
93. Larson EL. Persistent carriage of Gram-negative bacteria on hands. Am J Infect Control. 1981;9:112-119.
94. Getchell-White SI, Donowitz LG, Groschel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol. 1989;10:402-407.
95. Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest. 1997;112:1050-1054.
96. Husni RN, Goldstein, Arroliga AC, et al. Risk factors for an outbreak of multidrug resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest. 1999;115:1378-1382.
97. Dore P, Robert R, Grollier G, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Respir Crit Care Med. 1996;153:1292-1298.
98. Valles J, Mesalles E, Mariscal D, et al. A 7-year study of severe hospital-acquired pneumonia requiring ICU admission. Intensive Care Med. 2003;29:1981-1988.
99. Fields BS, Benson RF, Besser RE. Legionella and Legionnaires' disease: 25 years of investigation. Clin Microbiol Rev. 2002; 15:506-526.
100. Goetz A, Stout JE, Jacobs SL, et al. Nosocomial Legionnaires' disease discovered in community hospitals following cultures of the water system: seek and ye shall find. Am J Infect Control. 1998;26:8-11.
101. Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med (Lond). 2002;52:249-253.
102. Ramsey PG, Fife KH, Kackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med. 1982;97:813-820.
103. Bruynseels P, Jorens PG, Demey HE, et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet. 2003;362:1536-1541.
104. Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in non-immunosuppressed critically ill patients. Crit Care Med. 2001;29:541-547.
105. Papazian L, Fraisse A, Garbe L, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology. 1996;84:280-287.
106. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care. 2005;50:742-763.
107. Rello J, Esandi Me, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis. 1998;26:1473-1475.
108. Neiderman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;65:565-569.
109. Fagon YT, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis. 1988;138:110-116.
110. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121-1129.
111. Luyt CE, Chastre J, Fagon YT. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med. 2004; 30:844-852.
112. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31:676-682.
113. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;263:505-511.
114. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001;29:1109-1115.
115. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125:1791-1799.
116. Bonten MJ, Bermans DC, Stobberingh EE, et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med. 1997;156(6): 1820-1824.
117. Fagon YT, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med. 2000;132(8):621-630.
118. Brown DL, Hungness ES, Campbell RS, Luchette FA. Ventilator-associated pneumonia in the surgical critical care unit. J Trauma. 2001;51:1207-1216.
119. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest. 1992;102(5 Suppl 1):557S-564S.
120. Rouby JJ. Histology and microbiology of ventilator-associated pneumonias. Semin Respir Infect. 1996;11(1):54-61.
121. Trouillet JL, Guiguet M, Gilbert C, et al. Fiberoptic bronchoscopy in ventilated patients: evaluation of cardiopulmonary risk under midazolam sedation. Chest. 1990;97(4): 927-933.
122. Kerwin AJ, Croce MA, Timmons SD, Maxwell RA, Malhotra AK, Fabian TC. Effects of fiberoptic bronchoscopy on intracranial pressure in patients with brain injury: a prospective clinical study. J Trauma. 2000;48:878-892.
123. Baughmann RP. Nonbronchoscopic evaluation of ventilator-associated pneumonia. Semin Respir Infect. 2003;18(2): 95-102.
124. Wood AJ, Davit AJ, Ciraulo DL, et al. A prospective assessment of diagnostic efficacy of blind protective bronchial brushings compared to bronchoscope-assisted lave, bronchoscope-directs brushings and blind endotracheal aspirates in ventilator-associated pneumonia. J Trauma. 2003;55(5): 825-834.
125. Jorda R, Parras F, Ibanez J, Reina J, Bergada J, Raurich JM. Diagnosis of nosocomial pneumonia in mechanically ventilated patients by the blind protected telescoping catheter. Intensive Care Med. 1993;19(7):377-382.
126. Meduri GU, Reddy RC, Stanley T, El-Zeky F. Pneumonia in acute respiratory distress syndrome: a prospective evaluation of bilateral bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158(3):870-875.
127. Baselski VS, Wunderink RG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev. 1994;7(4):553-558.
128. Baselski V. Microbiologic diagnosis of ventilator-associated pneumonia. Infect Dis Clin North Am. 1993;7(2):331-357.
129. Croce MA, Fabian TC, Schurr MJ, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis. J Trauma. 1995;39:1134-1140.
130. Miller PR, Meredith JW, Chang MC. Optimal threshold for diagnosis of ventilator-associated pneumonia using bronchoalveolar lavage. J Trauma. 2003;55(2):263-268.
131. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis. 1987;155(5): 1019-1027.
132. Chastre J, Fagon YT, Bornet-Lesco M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med. 1995;152(1):231-240.
133. Allaouchiche B, Jaumain H, Chassard D, Bouletreau P. Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia. Br J Anaesth. 1999;83: 845-849.
134. Davis KA, Eckert MJ, Reed RL II, et al. Ventilator-associated pneumonia in the injured patient: do you trust your Gram stain? J Trauma. 2005;58(3):462-467.
135. Prats E, Dorva J, Pujol M, et al. Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J. 2002;19(5):944-951.
136. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis. 1993;147(1):38-44.
137. Souweine B, Veber B, Bedos JP, et al. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments. Crit Care Med. 1998;26(2):236-244.
138. Johanson WG Jr, Seidenfeld JJ, Gomez P, de los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechanical ventilation. Am Rev Respir Dis. 1998;137(2):259-264.
139. Rello J, Gallego M, Mariscal D, Sonor R, Valees J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156(1): 196-200.
140. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22(5):387-394.
141. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106(1):221-235.
142. Luna CM, Vijacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
143. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122: 262-268.
144. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcome: implications the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113:412-420.
145. Dupont H, Mentec H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27:355-362.
146. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531-539.
147. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia around 4 treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999;160:608-613.
148. Ibrahim EH, Ward S, Sherman G, et al. A comparative analysis of patients with early-onset and late-onset nosocomial pneumonia in the ICU setting. Chest. 2000;117:1434-1442.
149. Rello J, Diaz E. Optimal use of antibiotics for intubation-associated pneumonia. Intensive Care Med. 2001;27:337-339.
150. Sandiumenge A, Diaz E, Bodi M, Rello J. Treatment of ventilator- associated pneumonia: a patient-based approach based on the rules of the "Tarragona strategy." Intensive Care Med. 2003;29:876-883.
151. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of deescalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183-2196.
152. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial therapy. Crit Care Med. 2002;29:1473-1475.
153. Rello J, Paiva JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of ventilator-associated pneumonia. Chest. 2001;120:955-970.
154. Schentag JJ, Gilliland KK, Paladino JA. What have we learned from pharmacokinetic and pharmacodynamic theories? Clin Infect Dis. 2001;32:S39-S46.
155. Bodi M, Diaz E, Rello J. Appropriate antibiotic treatment for pneumonia. Clin Infect Dis. 2000;31:1313-1314.
156. Wysocki M, Thomas F, Wolff MA, Pean Y, Ravaud Y, Herman B. Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections. J Antimicrob Chemother. 1995;35:352-354.
157. Rubenstein E, Cammarata S, Oliphant T, et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nonoscomial pneumonia: a randomized double-blind multicenter study. Clin Infect Dis. 2001;32:402-412.
158. Wunderlink RG, Cammarata SK, Oliphant TH, et al. Continuation of a randomized double-blind multicenter trial of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther. 2003;25:980-992.
159. Kollef MH, Rello J, Croos-Dabrera RV, Cammarata SK, Wunderink RG. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of 2 double-blind studies comparing linezolid with vancomycin. Intensive Care Med. 2004;30:388-394.
160. James JK, Palmer SM, Levine DP, Ribak MJ. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented Gram-positive infections. Antimicrob Agents Chemother. 1996;40: 696-700.
161. Chastre J, Wolff M, Fagon YT, et al. Comparision of 8 vs. 15 days of antiobiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588-2598.
162. Ibanez J, Penfiel A, Raurich JM, Marse P, Jorda R, Mata F. Gastroesophageal reflux in intubated patients receiving enteral nutrition: effect of supine and semirecumbent positions. JPEN J Parenter Enteral Nutr. 1992;16:419-422.
163. Orozco-Levi M, Torres A, Ferrer M, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med. 1995;152:1387-1390.
164. Torres A, Sera-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 1992;116:540-543.
165. Drakulovic MB, Torres A, Bauer TT, Nicholas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet. 1999;354:1851-1858.
166. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
167. Guidelines for preventing health-care-associated pneumonia, 2003. Recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. Respir Care. 2004;49:929-939.
168. Chatte G, Sab JM, Dubois JM, Sirodot M, Gaussorgues P, Robert D. Prone position in mechanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med. 1997;155:473-478.
169. Pelosi P, Tubiolo D, Mascheroni D, et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med. 1998;157:387-393.
170. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568-573.
171. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004;292:2379-2387.
172. Beuret P, Carton M, Nourdine K, Kaaki M, Tramoni G, Ducreaux J. Prone position as prevention of lung injury in comatose patients: a prospective, randomized, controlled study. Intensive Care Med. 2002;28:564-569.
173. Keane F. Roto-rest. Paraplegia. 1970;7:254-258.
174. Gentilello L, Thompson DA, Tonnesen AS, et al. Effect of a rotating bed on the incidence of pulmonary complications in critically ill patients. Crit Care Med. 1998;16:783-786.
175. Summer WR, Curry P, Haponik EF, Nelson S, Elston R. Continuous mechanical turning of intensive care unit patients shortens length of stay in some diagnostic-related groups. J Crit Care. 1989;4:45-53.
176. Fink MP, Helsmoortel CM, Stein KL, Lee PC, Conn SM. The efficacy of an oscillating bed in the prevention of lower respiratory tracts infection in critically ill victims of blunt trauma: a prospective study. Chest. 1990;97:132-137.
177. Marik PE, Fink MP. One good turn deserves another! (editorial). Crit Care Med. 2002;30:2146-2148.
178. Choi SC, Nelson LD. Kinetic therapy in critically ill patients: combined results based on meta-analysis. J Crit Care. 1992;7:57-62.
179. Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA. 2000;284:2361-2367.
180. Bersten AD, Holt AW, Vedig AE, Skowronski GA, Baggoley CJ. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med. 1991;325:1825-1830.
181. Brochard L, Macebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333:817-821.
182. Koerner RJ. Contribution of endotracheal tubes to the pathogenesis of ventilator-associated pneumonia. J Hosp Infect. 1997;35:83-89.
183. Adair CG, Gorman SP, Feron BM, et al. Implications of endotracheal tube Biofilm for ventilator-associated pneumonia. Intensive Care Med. 1999;25:1072-1076.
184. Feldman C, Kassel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J. 1999;12:546-551.
185. Pacheco-Fowler V, Gaonkar T, Wyer PC, Modak S. Antiseptic impregnated endotracheal tubes for the prevention of bacterial colonization. J Hosp Infect. 2004;57:170-174.
186. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: incidence, prognosis and risk factors. ARDS Study Group. Am J Respir Crit Care Med. 2000;161:1942-1948.
187. Kollef M. Ventilator-associated pneumonia and ventilator-induced lung injury: two peas in a pod. Crit Care Med. 2002;30:2391-2392.
188. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
189. Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors and complications. Crit Care Med. 2001;29:1955-1961.
190. McClave SA, Lukan JK, Stafater JA, et al. Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med. 2005;33:324-330.
191. Kortbeek JB, Haigh PI, Doig C. Duodenal versus gastric feeding in ventilated blunt trauma patients: a randomized controlled trial. J Trauma. 1999;46:992-996.
192. Marik PE, Zaloga GP. Gastric versus post-pyloric feeding: a systematic review. Crit Care. 2003;7:46-51.
193. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004; 351: 327-336.
194. Ricart M. Management of airways in intubated patients. Clin Pulm Med 1997;4:148-151.
195. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 1995;122:179-186.
196. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective roles of mechanical subglottic secretion drainage and stress ulcer prophylaxis. Intensive Care Med. 1992;18:20-25.
197. Smulders K, van der Hoeven H, Weers-Pothoff I, Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest. 2002;121:858-862.
198. Dezfulian C, Shojania K, Collard HR, Kim HM, Matthay MA, Saint S. Subglottic secretion drainage for preventing ventilator-associated pneumonia: potential economic implications. Am J Med. 2005;118:11-18.
199. DeRiso AJ II, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996;109:1556-1561.
200. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Cut Care. 2002; 11:567-570.
201. Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med. 2000;26:1239-1247.
202. Grap MJ, Munro CL, Elswick RK Jr., Sessler CN, Ward KR. Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Heart Lung. 2004;33:83-91.
203. Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg. 1999;134:170-176.
204. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest. 1994;105;1101-1108.
205. Bonten MJ, Grundmann H. Selective digestive decontamination and antibiotic resistance: a balancing act. Crit Care Med. 2003;31:2239-2240.
206. Ebner W, Kropec-Hubner A, Daschner FD. Bacterial resistance and overgrowth due to selective decontamination of the digestive tract. Eur J Clin Microbiol Infect Dis. 2000;19:243-247.
207. Desmond P, Raman R, Idikula J. Effect of nasogastric tubes on the nose and maxillary sinus. Crit Care Med. 1991;19:509-511.
208. Salord F, Gaussorgues P, Marti-Flich J, et al. Nonocomial maxiallry sinusitis during mechanical ventilation: a prospective comparison of orotracheal versus the nasotracheal route for intubation. Intensive Care Med. 1990;16:390-393.
209. Holzapfel L, Chastang C, Demingeon G, Bohe J, Piralla B, Coupry A. A randomized study assessing the systemic search for maxillary sinusitis in nasotracheally mechanically ventilated patients: influence of nosocomial maxillary sinusitis on the occurrence of ventilator-assosciated pneumonia. Am J Respir Crit Care Med. 1999;159:695-701.
210. Rouby JJ, Laurent P, Gosnach M, et al. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med. 1994;150:776-783.
211. Ely WE, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. New Engl J Med. 1996;335:1864-1869.
212. Kollef MH, Shapiro SD, Silver P, et al. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med. 1997;25:567-574.
213. Boulain T; the Association des Reanimateurs de Centre-Ouest. Unplanned extubations in the adult intensive care unit: a prospective multicenter study. Am J Respir Crit Care Med. 1998;157:1131-1137.
214. Torres A, Gatell JM, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med. 1995;152:137-141.
215. Tominaga GT, Rudzwick H, Scannell G, Waxman K. Decreasing unplanned extubations in the surgical intensive care unit. Am J Surg. 1995;170:586-590.
216. Kollef MH, Levy NT, Aherns TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998; 114:541-548.
217. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. New Engl J Med. 2000;342:1471-1477.